Skip to content

6-KAccepted Jun 23, 4:13 PM ET

Agomab Therapeutics NV 6-K

AGMBAgomAb Therapeutics NV

Accepted (ET)

4:13 PM

Jun 23, 2026

Filed

Jun 23, 2026

Documents

3

Size

60.8 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.